NOVAN

novan-logo

Novan develops products that tap the anti-bacterial properties of nitric oxide by encapsulating the compound in nano-particles that deliver therapeutic agents to desired body location. They use its proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs. The company is committed to using the power of the human body to create safe and effective treatments. They complement their internal scientific talent with strategic partners around the globe to enable Novan to harness the power of nitric oxide and develop technologies that will help address currently untreated and under-treated medical conditions. It was incorporated in 2008 and is based in Morrisville, North Carolina.

#SimilarOrganizations #People #Financial #Event #Website #More

NOVAN

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2008-01-01

Address:
Morrisville, North Carolina, United States

Country:
United States

Website Url:
http://www.novan.com

Total Employee:
101+

Status:
Active

Contact:
919-485-8080

Email Addresses:
[email protected]

Total Funding:
210.44 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

ansun-biopharma-logo

Ansun BioPharma

Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.

lineage-cell-therapeutics-logo

Lineage Cell Therapeutics

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

knopp-biosciences-logo

Knopp Biosciences

Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.

palisade-bio-logo

Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.

Current Employees Featured

john-m-gay_image

John M. Gay
John M. Gay VP, Finance and Corporate Controller @ Novan
VP, Finance and Corporate Controller
2019-01-01

paula-brown-stafford_image

Paula Brown Stafford
Paula Brown Stafford Chief Executive Officer & Board Member @ Novan
Chief Executive Officer & Board Member
2020-02-01

carri-geer_image

Carri Geer
Carri Geer SVP & Chief Technology Officer @ Novan
SVP & Chief Technology Officer
2018-11-01

elizabeth-messersmith_image

Elizabeth Messersmith
Elizabeth Messersmith Chief Development Officer (CDO) @ Novan
Chief Development Officer (CDO)
2019-01-01

Founder


nathan-stasko_image

Nathan Stasko

Stock Details


Company's stock symbol is NASDAQ:NOVN

Acquisitions List

Date Company Article Price
2022-03-11 EPI Health EPI Health acquired by Novan N/A

Investors List

u-s-department-of-defense_image

U.S. Department of Defense

U.S. Department of Defense investment in Grant - Novan

aspire-capital-fund_image

Aspire Capital Partners LLC

Aspire Capital Partners LLC investment in Post-IPO Equity - Novan

malin-corporation-plc_image

Malin Corporation

Malin Corporation investment in Private Equity Round - Novan

Official Site Inspections

http://www.novan.com Semrush global rank: 9.75 M Semrush visits lastest month: 113

  • Host name: 151.101.66.159
  • IP address: 151.101.66.159
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Novan"

Novan - Crunchbase Company Profile & Funding

Novan develops products that tap the anti-bacterial properties of nitric oxide by encapsulating the compound in nano-particles that deliver therapeutic agents to desired body location. They use …See details»

Novan, Inc. - AnnualReports.com

Novan, Inc. is a clinical development-stage biotechnology company focused on leveraging its proprietary nitric oxide (NO) based technology platform, …See details»

Novan Advances Organization and Strengthens Leadership Team

Apr 12, 2018 CEO Role No Longer “Interim” Clinical Operations Role Established Finance Team Positioned for the Future MORRISVILLE, N.C., April 12, 2018 — Novan, Inc. (“the Company” …See details»

Novan - Org Chart, Teams, Culture & Jobs - The Org

Novan, Inc. is a late-stage pharmaceutical company focused on redefining the standard of care in dermatology through the development and commercialization of innovative therapies using the …See details»

Novan Company Profile - Office Locations, Competitors, Revenue …

Feb 22, 2022 Novan is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological …See details»

Novan - Operations and Administration - The Org

The Operations and Administration team at Novan is responsible for optimizing internal processes and ensuring efficient resource management to support the company’s mission in …See details»

Novan, Inc. Overview | SignalHire Company Profile

Novan, Inc. is a medical dermatology company primarily focused on researching, developing and commercializing innovative therapeutic products for skin diseases. ... Organization Website: …See details»

Novan - Overview, News & Similar companies | ZoomInfo.com

Jun 4, 2024 Who is Novan. Founded in 2006, based out of Durham, North Carolina, Novan, Inc. is a clinical development-stage biotechnology company focused on leveraging nitri c oxide's …See details»

Novan - Contacts, Employees, Board Members, Advisors & Alumni …

Novan is a clinical-stage drug development company developing deliverable nitric oxide.See details»

Novan - Funding, Financials, Valuation & Investors - Crunchbase

Novan is registered under the ticker NASDAQ:NOVN . Their stock opened with $11.00 in its Sep 21, 2016 IPO. Novan is funded by 4 investors. Ligand Pharmaceuticals and U.S. Department …See details»

Novan - Verify.Wiki - Verified Encyclopedia

Novan, Inc. is a late-stage pharmaceutical company focused on redefining the standard of care in dermatology through the development and commercialization of innovative therapies using the …See details»

Novan Announces Strategic Priorities and Outlines Key Milestones

Novan, Inc. Thu, Sep 9, 2021, 7:00 AM 9 min read – Company planning for three potential New Drug Application (NDA) filings in three years with the first submission expected in Q3 2022 for …See details»

Novan Moves Forward with Unified Corporate Branding

Mar 8, 2023 – EPI Health adopts Novan corporate branding, ... and a network of related partners. The combined organization is a fully integrated pharmaceutical company with …See details»

Novan - Company Profile - Tracxn

Dec 7, 2024 Novan. has raised a total funding of $102M over 13 rounds. Its first funding round was on Jun 25, 2009. What are the most recent funding rounds of Novan? Its latest funding …See details»

Novan Moves Forward with Unified Corporate Branding

Mar 8, 2023 – Novan is a fully integrated pharmaceutical company with proven ... The combined organization is a fully integrated pharmaceutical company with capabilities across drug …See details»

Novan Reshapes Executive Management Team

Mar 22, 2017 Former Quintiles Executive Paula Brown Stafford Joins Novan as Chief Development Officer Stanley Hollenbach Promoted to Senior Vice President of Research and …See details»

Novan Inc (NOVN-Q) Stock Price and News - The Globe and Mail

Real-time Price Updates for Novan Inc (NOVN-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»

Novan Expands External Business Partner Network

Jun 19, 2019 Expansion of the existing relationship with MedPharm around formulation science Manufacturing agreement established for production of proprietary drug substance Partner …See details»

Novan Announces Strategic Priorities and Outlines Key

Sep 9, 2021 Novan is developing SB204 as a topical monotherapy for the treatment of acne vulgaris. This form of acne represents a multi-factorial disease with varying disease pathology …See details»

Novan Announces $6.0 Million Registered Direct Offering

Mar 14, 2023 Article content. DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it has entered into …See details»

linkstock.net © 2022. All rights reserved